Medtronic PLC Stock Underperforms Wednesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Medtronic PLC (MDT) shares fell 1.23% to $92.60 on Wednesday, underperforming competitors like Johnson & Johnson and Abbott Laboratories during a broad market decline. This marks the second consecutive day of losses for Medtronic, which is now trading 12.91% below its 52-week high. Trading volume reached 9.9 million, exceeding the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Medtronic PLC (MDT) slipped 1.23% to $92.60 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.45% to 7,551.81 and Dow Jones Industrial Average falling 1.21% to 51,461.90.
This was the stock's second consecutive day of losses.
Medtronic PLC closed 12.91% below its 52-week high of $106.33, which the company reached on November 26th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 0.03% to $267.28, Danaher Corp. (DHR) fell 0.48% to $208.36, and Abbott Laboratories (ABT) rose 0.32% to $102.36.
Trading volume (9.9 M) eclipsed its 50-day average volume of 7.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 16, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-16-26 1637ET